Table 1 Demographic, clinical, and treatment characteristics of included patients
Characteristics | Total | Placebo | Gentamicin/Placebo | Gentamicin |
|---|---|---|---|---|
n = 15 | n = 5 | n = 4 | n = 5 | |
Sex | ||||
Male | 8 (53%) | 1 (20%) | 4 (100%) | 3 (60%) |
Age (mean, (SD)) | 64.8 (12.5) | 57.3 (16.7) | 72.6 (5) | 64.5 (8) |
Duration of MD in years (median (range)) | 3 (0.1-19.6) | 2.5 (0.1-18.2) | 3.3 (0.7-7.5) | 3.1 (1.1-19.6) |
DHI | 48.6 (20.0) | 54.0 (18.0) | 40.5 (16.4) | 51.2 (25.5) |
Averaged (0.5, 1, 2, 4 kHz) pure-tone-hearing loss (dB HL) | ||||
Right | 41.2 (19.9) | 35.0 (24.5) | 29.7 (7.4) | 59.0 (8.6) |
Left | 50.6 (23.7) | 43.8 (21.6) | 61.3 (30.7) | 46.8 (21.3) |